Sustained long-term benefit of sildenafil in primary pulmonary hypertension

Sayin T., Ozenci M.

ACTA CARDIOLOGICA, vol.62, no.1, pp.47-49, 2007 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 62 Issue: 1
  • Publication Date: 2007
  • Doi Number: 10.2143/ac.62.1.2019370
  • Journal Name: ACTA CARDIOLOGICA
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.47-49
  • Keywords: sildenafil, pulmonary hypertension, INHALED ILOPROST, ORAL SILDENAFIL
  • Ankara University Affiliated: No

Abstract

Primary pulmonary hypertension is a rare disease with an ominous prognosis for which new therapeutic options are being developed. Recently, there have been case reports indicating that sildenafil may be of benefit in short-to midterm follow-up. However, long-term clinical data of sildenafil in primary pulmonary hypertensive patients is lacking. We report a patient with primary pulmonary hypertension treated with sildenafil 200 mg/day for 50 months with a sustained clinical response.